SCHEMBL7040372

SCHEMBL7040372

CCOCC1(C)CN(C(=O)O)CCC1(O)c1ccc(Cl)cc1

nearest known ligand 0.45

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 19/20 0.45
APP P05067 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL652654 0.87 CCR1 (0.47) CCR1
SCHEMBL3026041 0.79 CCR1 (0.50) CCR1
SCHEMBL1605171 0.79 CCR1 (0.62) CCR1
SCHEMBL655872 0.78 CCR1 (0.43) CCR1APP
SCHEMBL10291838 0.76 CCR1 (0.59) CCR1
SCHEMBL653412 0.75 CHRM2 (0.44) CCR1
SCHEMBL2158968 0.75 CCR1 (0.53) CCR1
SCHEMBL654564 0.74 CCR1 (0.48) CCR1
SCHEMBL653478 0.72 SLC6A2 (0.46)
SCHEMBL10291813 0.71 CCR1 (0.64) CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1448566-A2 CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2004-08-25 EP disclosed
WO-2003045942-A2 CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2003-06-05 WO disclosed